Editorial: Lessons on T-Cells and Immune-Targeting Therapeutics in Coeliac Disease

by Melinda Y. Hardy, Melinda Y. Hardy, Daniel Agardh, Robert P. Anderson
Published 2021-09-01

Preparation and Characterization of Avenin-Enriched Oat Protein by Chill Precipitation for Feeding Trials in Celiac Disease

by Greg Tanner, Angéla Juhász, Christakis George Florides, Mitchell Nye-Wood, Frank Békés, Michelle L. Colgrave, Amy K. Russell, Amy K. Russell, Melinda Y. Hardy, Melinda Y. Hardy, Jason A. Tye-Din, Jason A. Tye-Din, Jason A. Tye-Din, Jason A. Tye-Din
Published 2019-10-01

Circulating gluten‐specific, but not CMV‐specific, CD39+ regulatory T cells have an oligoclonal TCR repertoire

by Laura Cook, C Mee Ling Munier, Nabila Seddiki, Melinda Y Hardy, Robert P Anderson, John Zaunders, Jason A Tye‐Din, Anthony D Kelleher, David vanBockel
Published 2020-01-01

A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disea...

by Melinda Y. Hardy, Melinda Y. Hardy, Gautam Goel, Amy K. Russell, Amy K. Russell, Swee Lin G. Chen Yi Mei, Gregor J. E. Brown, Suyue Wang, Evan Szymczak, Ruan Zhang, Kaela E. Goldstein, Kristin M. Neff, Leslie J. Williams, Kenneth E. Truitt, John L. Dzuris, Jason A. Tye-Din, Jason A. Tye-Din, Jason A. Tye-Din, Robert P. Anderson
Published 2021-05-01